Category: Workers Comp

558 posts found

Medmonitor

FDA Approves Oral Tablet Formulation of Wegovy

This approval marks the arrival of the first oral GLP-1 semaglutide drug.

This Month's Must Read

Creeping Costs: The Rise of Mega Claims in Workers’ Compensation

A small percentage of claims drive the majority of costs in workers’ comp. How can mega claims be mitigated?

Marijuana Developments

White House Issues Executive Order to Reschedule Marijuana

Rescheduling marijuana to Schedule III will allow for greater clinical research, possible FDA-approved drugs, and more.

Legislation & Policy

States Consider Expanding Presumptions

So far in 2026, eight states and counting are seeking to expand existing presumptions or create new presumptions.

Innovation

Could AI-Designed Drugs Impact Regulatory Frameworks?

While AI can be effective in some elements of drug design, AI models currently struggle to explain their decision making, a key component of drug review.

Healthe Developments

Preliminary Findings from the 2026 Workers’ Comp Industry Insights Survey Report

Risk & Insurance® magazine published high-level findings from the eighth annual survey, in collaboration with Healthesystems.

Medmonitor

CMS Drug Pricing Negotiation to Lower Costs of 15 Drugs

The 2025 negotiations covered drugs for obesity, cancer, diabetes, COPD, asthma, and more.

This Month's Must Read

The Injured Worker: An Essential, Sometimes Overlooked Partner in Improving Pharmacy Network Utilization

Engaging directly with injured workers is one important way to improve pharmacy network utilization in workers’ comp.

Marijuana Updates

JAMA Publishes New Review for Therapeutic Use of Cannabis

The review examines the efficacy of cannabis therapy for various indications, including chronic pain and psychiatric conditions.

Industry Trends

Minnesota Reports on Prescription Drug Price Transparency

Drug classes with the most new, high-priced drugs were anti-cancer drugs, ADHD/anti-obesity drugs, and anti-inflammatory pain medications.

Legislation & Policy

New York Could Remove References to CDC Guidelines

After regional public health collaboratives formed in September, New York could be the first state to formally shift policies away from deferring to federal guidelines.